These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33473265)

  • 1. Fisetin: An anticancer perspective.
    Imran M; Saeed F; Gilani SA; Shariati MA; Imran A; Afzaal M; Atif M; Tufail T; Anjum FM
    Food Sci Nutr; 2021 Jan; 9(1):3-16. PubMed ID: 33473265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fisetin regulates TPA-induced breast cell invasion by suppressing matrix metalloproteinase-9 activation via the PKC/ROS/MAPK pathways.
    Noh EM; Park YJ; Kim JM; Kim MS; Kim HR; Song HK; Hong OY; So HS; Yang SH; Kim JS; Park SH; Youn HJ; You YO; Choi KB; Kwon KB; Lee YR
    Eur J Pharmacol; 2015 Oct; 764():79-86. PubMed ID: 26101063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fisetin inhibits laryngeal carcinoma through regulation of AKT/NF-κB/mTOR and ERK1/2 signaling pathways.
    Zhang XJ; Jia SS
    Biomed Pharmacother; 2016 Oct; 83():1164-1174. PubMed ID: 27551764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fisetin: a dietary antioxidant for health promotion.
    Khan N; Syed DN; Ahmad N; Mukhtar H
    Antioxid Redox Signal; 2013 Jul; 19(2):151-62. PubMed ID: 23121441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the molecular targets of dietary flavonoid fisetin in cancer.
    Syed DN; Adhami VM; Khan N; Khan MI; Mukhtar H
    Semin Cancer Biol; 2016 Oct; 40-41():130-140. PubMed ID: 27163728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary flavonoid fisetin targets caspase-3-deficient human breast cancer MCF-7 cells by induction of caspase-7-associated apoptosis and inhibition of autophagy.
    Yang PM; Tseng HH; Peng CW; Chen WS; Chiu SJ
    Int J Oncol; 2012 Feb; 40(2):469-78. PubMed ID: 21922137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fisetin inhibits migration and invasion of human cervical cancer cells by down-regulating urokinase plasminogen activator expression through suppressing the p38 MAPK-dependent NF-κB signaling pathway.
    Chou RH; Hsieh SC; Yu YL; Huang MH; Huang YC; Hsieh YH
    PLoS One; 2013; 8(8):e71983. PubMed ID: 23940799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fisetin inhibits growth, induces G₂ /M arrest and apoptosis of human epidermoid carcinoma A431 cells: role of mitochondrial membrane potential disruption and consequent caspases activation.
    Pal HC; Sharma S; Elmets CA; Athar M; Afaq F
    Exp Dermatol; 2013 Jul; 22(7):470-5. PubMed ID: 23800058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin.
    Lim DY; Park JH
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1060-8. PubMed ID: 19264955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Dietary Flavonoid Fisetin Causes Cell Cycle Arrest, Caspase-Dependent Apoptosis, and Enhanced Cytotoxicity of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells.
    Smith ML; Murphy K; Doucette CD; Greenshields AL; Hoskin DW
    J Cell Biochem; 2016 Aug; 117(8):1913-25. PubMed ID: 26755433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-kappaB-signaling pathways.
    Suh Y; Afaq F; Johnson JJ; Mukhtar H
    Carcinogenesis; 2009 Feb; 30(2):300-7. PubMed ID: 19037088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fisetin suppresses migration, invasion and stem-cell-like phenotype of human non-small cell lung carcinoma cells via attenuation of epithelial to mesenchymal transition.
    Tabasum S; Singh RP
    Chem Biol Interact; 2019 Apr; 303():14-21. PubMed ID: 30802432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary flavonoid fisetin for cancer prevention and treatment.
    Lall RK; Adhami VM; Mukhtar H
    Mol Nutr Food Res; 2016 Jun; 60(6):1396-405. PubMed ID: 27059089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation.
    Sung B; Pandey MK; Aggarwal BB
    Mol Pharmacol; 2007 Jun; 71(6):1703-14. PubMed ID: 17387141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The flavonoid fisetin as an anticancer agent targeting the growth signaling pathways.
    Rengarajan T; Yaacob NS
    Eur J Pharmacol; 2016 Oct; 789():8-16. PubMed ID: 27377217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory effect of intravesical fisetin against bladder cancer by induction of p53 and down-regulation of NF-kappa B pathways in a rat bladder carcinogenesis model.
    Li J; Qu W; Cheng Y; Sun Y; Jiang Y; Zou T; Wang Z; Xu Y; Zhao H
    Basic Clin Pharmacol Toxicol; 2014 Oct; 115(4):321-9. PubMed ID: 24646039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fisetin induces apoptosis and endoplasmic reticulum stress in human non-small cell lung cancer through inhibition of the MAPK signaling pathway.
    Kang KA; Piao MJ; Madduma Hewage SR; Ryu YS; Oh MC; Kwon TK; Chae S; Hyun JW
    Tumour Biol; 2016 Jul; 37(7):9615-24. PubMed ID: 26797785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells.
    Khan N; Afaq F; Syed DN; Mukhtar H
    Carcinogenesis; 2008 May; 29(5):1049-56. PubMed ID: 18359761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fisetin, a phytopolyphenol, targets apoptotic and necroptotic cell death in HepG2 cells.
    Sundarraj K; Raghunath A; Panneerselvam L; Perumal E
    Biofactors; 2020 Jan; 46(1):118-135. PubMed ID: 31634424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fisetin inhibits liver cancer growth in a mouse model: Relation to dopamine receptor.
    Liu XF; Long HJ; Miao XY; Liu GL; Yao HL
    Oncol Rep; 2017 Jul; 38(1):53-62. PubMed ID: 28560391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.